Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trialPatricia Kissinger, David H. Martin, Rebecca Lillis et al.|The Lancet Infectious Diseases|2018Cited by 78
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Vimla Naicker, Stephanie E. Cohen et al.|The Lancet|2025Cited by 26